Effectiveness and safety of mepolizumab in severe refractory eosinophilic asthma: results in clinical practice

BACKGROUND: Asthma is an inflammatory disease of the airways with symptoms that vary over time and intensity, sometimes leading to disability or even death. Eosinophilic asthma accounts for 25% of cases of severe asthma. It is mediated by eosinophils regulated by interleukin-5 (IL-5), the target of...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero-Pérez, Olalla, Contreras-Rey, María Beatriz, Sánchez-Gómez, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544138/
https://www.ncbi.nlm.nih.gov/pubmed/31191705
http://dx.doi.org/10.7573/dic.212584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544138/
https://www.ncbi.nlm.nih.gov/pubmed/31191705
http://dx.doi.org/10.7573/dic.212584

Ejemplares similares